远程医疗公司Hims & Hers Health Inc.股价在盘前交易时段飙升37.9%，表现异常强劲。这一显著上涨源于一则市场报告，该报告指出，制药巨头诺和诺德（Novo Nordisk）计划通过Hims & Hers Health的平台销售其广受欢迎的减肥药物。此举被视为对Hims & Hers业务模式的重要认可，并可能为其开辟巨大的新收入来源。投资者对此消息反应热烈，推动公司市值大幅增长。
远程医疗公司Hims & Hers Health Inc.股价在盘前交易时段飙升37.9%，表现异常强劲。这一显著上涨源于一则市场报告，该报告指出，制药巨头诺和诺德（Novo Nordisk）计划通过Hims & Hers Health的平台销售其广受欢迎的减肥药物。此举被视为对Hims & Hers业务模式的重要认可，并可能为其开辟巨大的新收入来源。投资者对此消息反应热烈，推动公司市值大幅增长。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.